By Anirban Sen
NEW YORK, Jan 6 (Reuters) - Medical-device maker Stryker
SYK.N is in advanced talks to acquire Inari Medical NARI.O ,
which makes devices that treat patients with venous diseases,
people familiar with the matter told Reuters on Monday.
If the talks are successful, a deal could be announced as
soon as this week, the sources said, requesting anonymity as the
discussions are confidential.
A deal for Inari, which has a market value of nearly $3
billion, would bolster Stryker's efforts to build out its
offerings to treat a blood-vein clotting condition called venous
thromboembolism and other venous diseases.
Inari has been working with its advisers to explore a sale
in recent weeks after fielding inbound acquisition interest from
Stryker and other parties, the sources said, cautioning that
another suitor could approach Inari and it is possible that no
deal with any party is reached.
Stryker and Inari did not immediately respond to requests
for comment.
(Reporting by Anirban Sen in New York; additional reporting by
Sabrina Valle and Milana Vinn; Editing by Lisa Shumaker)
((Anirban.Sen@thomsonreuters.com; Twitter: @asenjourno; Reuters
Messaging: Signal/Telegram/Whatsapp - +1-646-705-9409))